Direct Meds vs GoodRx
Direct Meds has an open FDA warning letter dated September 9, 2025. GoodRx has none. No price lines up like for like: Direct Meds and GoodRx publish prices for different products.
To see where both sit among the other sellers, read our best weight-loss injection providers board.
The record
Direct Meds / GoodRx
Featured pick (affiliate partner)
Direct Meds
7.1/10
GoodRx
7.8/10
Direct Meds is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. GoodRx pays us nothing. The scores are computed the same way for both and are shown as computed (Direct Meds 7.1, GoodRx 7.8). How we are paid
What the record shows
- 01
Direct Meds has an open FDA warning letter dated September 9, 2025. GoodRx has none.
- 02
Direct Meds names no compounding pharmacy in our record. GoodRx sells brand-name medication only.
- 03
No price lines up like for like: Direct Meds and GoodRx publish prices for different products.
- 04
Only Direct Meds lists a price for compounded semaglutide injection, compounded tirzepatide injection and compounded oral semaglutide. Only GoodRx lists a price for brand-name tirzepatide pen and Foundayo (orforglipron) pill.
- 05
Direct Meds covers one state GoodRx does not and GoodRx covers one state Direct Meds does not.
- 06
Direct Meds holds you to a 90-day supply shipped at once, remaining months billed every 30 days; GoodRx states you can cancel at any time.
Prices and terms, product by product
A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.
Direct Meds
GoodRx
$297/mo
$3,564 a year
$399/mo
$4,788 a year
$299/mo
$3,588 a year
$249/mo
$2,988 a year
$299/mo
$3,588 a year
$149/mo
$1,788 a year
Read off each seller’s own pages. Direct Meds: October 17, 2026. GoodRx: October 30, 2026. Every plan and dose we hold is on the full review.
The case for each
The case for Direct Meds
7.1/10- Sells compounded semaglutide injection and compounded tirzepatide injection, which GoodRx does not price
- Open FDA warning letter, September 9, 2025
- Names no compounding pharmacy
- Minimum commitment before you can cancel
The case for GoodRx
7.8/10- No FDA warning letter on record
- Sells brand-name tirzepatide pen and Foundayo (orforglipron) pill, which Direct Meds does not price
- States you can cancel at any time
Scores
Direct Meds 7.1 · GoodRx 7.8 out of 10. Six weighted parts.
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
The score is the same formula for every seller. Payment does not enter it. Method
Direct Meds vs GoodRx: questions
Other sellers we are paid by
Affiliate partners outside this pair. Each has its own record and review, scored the same way.
- Gala8.5
From $179/mo
Visit site - Sesame Care8.1
From $149/mo
Visit site - Oak7.2
From $100/mo
Visit site
Sellers closest to these two
- Direct Meds vs Henry Meds
- Direct Meds vs Fridays
- Direct Meds vs RxSpan MD
- Direct Meds vs Wellorithm
- GoodRx vs Hims
- GoodRx vs Ro
Matched on molecule, form and price. Every pair we list · The register
Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks